Back to results
US 2026/0202420 A1Published application
Method for the detection of cancer
AssigneeBelgian Volition SPRL
InventorsJacob Vincent MICALLEF, Mark Edward ECCLESTON, Marielle HERZOG, Jason Bradley TERRELL
Life of this patent
Estimating the term…
Abstract
The invention relates to body fluid test methods for the detection of cancer using a combination biomarker panel comprising at least one cytokine molecule and at least one cell free chromatin fragment.
Claims20
A method for diagnosing and/or monitoring a cancer, comprising:
- detecting or measuring a panel of biomarkers in a body fluid sample, wherein the panel of biomarkers comprises at least one cell free chromatin fragment and at least one cytokine molecule.
A method of treating cancer in a patient, comprising;
- (i) detecting or measuring at least one cytokine molecule and at least one cell free chromatin fragment, in a body fluid sample obtained from the patient;
- (ii) using the level of the cytokine molecule and the cell free chromatin fragment detected in the body fluid sample to determine if the patient has cancer;
- and
- (iii) administering a treatment to the patient if they are determined to have cancer in step (ii).
1 more element
A panel comprising reagents to detect the level of at least one cytokine molecule and the level of at least one cell free chromatin fragment in a body fluid sample.
Dependencies are inferred from the claim text.